John Nakayama

3.2k total citations · 1 hit paper
29 papers, 502 citations indexed

About

John Nakayama is a scholar working on Reproductive Medicine, Surgery and Obstetrics and Gynecology. According to data from OpenAlex, John Nakayama has authored 29 papers receiving a total of 502 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Reproductive Medicine, 9 papers in Surgery and 9 papers in Obstetrics and Gynecology. Recurrent topics in John Nakayama's work include Ovarian cancer diagnosis and treatment (10 papers), Endometrial and Cervical Cancer Treatments (8 papers) and Uterine Myomas and Treatments (4 papers). John Nakayama is often cited by papers focused on Ovarian cancer diagnosis and treatment (10 papers), Endometrial and Cervical Cancer Treatments (8 papers) and Uterine Myomas and Treatments (4 papers). John Nakayama collaborates with scholars based in United States, South Korea and Egypt. John Nakayama's co-authors include Katherine Moxley, David M. O’Malley, Paul DiSilvestro, Matthew A. Powell, Virginia L. Filiaci, Margaret M. Steinhoff, David S. Miller, Marcus E. Randall, David G. Mutch and Daniela Matei and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Obstetrics and Gynecology.

In The Last Decade

John Nakayama

25 papers receiving 497 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Adjuvant Chemotherapy plus Radiation for Locally Advanced Endometrial Cancer

2019 289 citations Daniela Matei, Virginia L. Filiaci et al. profile →

Peers

Countries citing papers authored by John Nakayama

Since Specialization

Citations

This map shows the geographic impact of John Nakayama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Nakayama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Nakayama more than expected).

Fields of papers citing papers by John Nakayama

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Nakayama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Nakayama. The network helps show where John Nakayama may publish in the future.

Co-authorship network of co-authors of John Nakayama

This figure shows the co-authorship network connecting the top 25 collaborators of John Nakayama. A scholar is included among the top collaborators of John Nakayama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Nakayama. John Nakayama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Müllerian clear cell carcinoma arising from rectal endometriosis with pericolonic lymph node metastasis 2024 ·Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin ·(unknown), John Nakayama, Emily Steinhagen, (unknown), Min Cui	0
2	Tyrosine kinase inhibitor toxicities: A society of gynecologic oncology review and recommendations 2023 ·Gynecologic Oncology ·B.J. Rimel, Erin K. Crane, June Y. Hou, John Nakayama, Jennifer MacDonald, (unknown), Vicky Makker, Roisin E. O’Cearbhaill	6
3	The Negative Impact of the COVID-19 Pandemic on Oncology Care at an Academic Cancer Referral Center 2021 ·PubMed ·John Nakayama, (unknown), Gino Cioffi, Kristin Waite, Nirav Patil, (unknown), John Shanahan, Paolo F. Caimi, Jill S. Barnholtz‐Sloan	5
4	Patient reported outcomes for cisplatin and radiation followed by carboplatin/paclitaxel versus carboplatin/paclitaxel for locally advanced endometrial carcinoma: An NRG oncology study 2021 ·Gynecologic Oncology ·Ursula A. Matulonis, Helen Huang, Virginia L. Filiaci, Marcus E. Randall, Paul DiSilvestro, Katherine Moxley, Jeffrey M. Fowler, Matthew A. Powell, Nick M. Spirtos, Krishnansu S. Tewari, William E. Richards, John Nakayama, David G. Mutch, David S. Miller, Daniela Matei, Lari Wenzel	4
5	Up-Front Multigene Panel Testing for Cancer Susceptibility in Patients With Newly Diagnosed Endometrial Cancer: A Multicenter Prospective Study 2021 ·JCO Precision Oncology ·(unknown), Rachel Pearlman, Heather Hampel, Casey Cosgrove, David E. Cohn, Alexis Chassen, Adrian A. Suarez, David A. Mix Barrington, Joseph McElroy, Steven Waggoner, John Nakayama, Caroline C. Billingsley, (unknown), Stephen Andrews, Sareena Singh, Eric L. Jenison, Aine Clements, Robert Neff, Paul J. Goodfellow, (unknown)	17
6	Gynecologic Surgery Proportion and Utilization Trends in the NSQIP Database from 2010 Through 2015 with Correlation to Technology and Policy 2021 ·Journal of Gynecologic Surgery ·John Nakayama, David Sheyn, Amr Mahran, Sherif A. El‐Nashar	1
7	Adjusting to the new reality: Evaluation of early practice pattern adaptations to the COVID-19 pandemic 2020 ·Gynecologic Oncology ·John Nakayama, Sherif A. El‐Nashar, Steven Waggoner, Bryan Traughber, Joshua P. Kesterson	25
8	Gender differences in authorship of obstetrics and gynecology publications during the coronavirus disease 2019 pandemic 2020 ·American Journal of Obstetrics & Gynecology MFM ·Julia Cook, Megha Gupta, John Nakayama, Sherif A. El‐Nashar, Joshua P. Kesterson, Stephen Wagner	7
9	The association between progesterone receptor expression and survival in women with adult granulosa cell tumors 2019 ·Gynecologic Oncology ·(unknown), James A. Edwards, (unknown), John Nakayama, Sarah M. Bean, Paola A. Gehrig, (unknown), Linda Duska, Gloria Broadwater, Jessie Ehrisman, Neil S. Horowitz, Angeles Alvarez Secord	7
10	The ovarian cancer message isn’t getting out: Using Google search data to gauge ovarian cancer awareness 2019 ·Gynecologic Oncology ·(unknown), (unknown), (unknown), Christian Jackson, E. Hopp, John Nakayama	1
11	Prior breast cancer and tamoxifen exposure does not influence outcomes in women with uterine papillary serous carcinoma 2017 ·Gynecologic Oncology ·(unknown), J.E. Stine, Paola A. Gehrig, Laura J. Havrilesky, Angeles Alvarez Secord, John Nakayama, Anna C. Snavely, Dominic T. Moore, Kenneth H. Kim	9
12	3T multiparametric MRI–guided high-dose-rate combined intracavitary and interstitial adaptive brachytherapy for the treatment of cervical cancer with a novel split-ring applicator 2017 ·Brachytherapy ·(unknown), Bryan Traughber, Tarun K. Podder, Valdir Colussi, (unknown), Suzanne Russo, Karin A. Herrmann, Raj Mohan Paspulati, Steven Waggoner, Kristine Zanotti, Christa Nagel, John Nakayama, Mitchell Machtay, Rodney J. Ellis	8
13	A randomized phase III trial of cisplatin and tumor volume directed irradiation followed by carboplatin and paclitaxel vs. carboplatin and paclitaxel for optimally debulked, advanced endometrial carcinoma. 2017 ·Journal of Clinical Oncology ·Daniela Matei, Virginia L. Filiaci, Marcus E. Randall, Margaret M. Steinhoff, Paul DiSilvestro, Katherine Moxley, Byoung Soo Kim, Matthew A. Powell, David M. O’Malley, Nicola M. Spirtos, Krishnansu S. Tewari, (unknown), John Nakayama, David G. Mutch, David S. Miller	49
14	Preliminary Outcomes of MRI-Guided High Dose Rate Combined Intracavitary and Interstitial Brachytherapy at a Single Institution 2016 ·Brachytherapy ·(unknown), Bryan Traughber, Tarun K. Podder, Valdir Colussi, (unknown), Suzanne Russo, Karin A. Herrmann, Raj Mohan Paspulati, Steven Waggoner, Kristine Zanotti, Christa Nagel, John Nakayama, Mitchell Machtay, Rodney J. Ellis	1
15	The Risk Factors of Readmission in Postoperative Gynecologic Oncology Patients at a Single Institution 2015 ·International Journal of Gynecological Cancer ·John Nakayama, (unknown), C. Friedman, Mark E. Smolkin, Linda Duska	13
16	Laparoscopy compared to laparotomy in the management of granulosa cell tumors of the ovary 2015 ·Gynecologic Oncology ·John Nakayama, (unknown), (unknown), James M. Edwards, J.E. Stine, Angeles Alvarez Secord, Paola A. Gehrig, Linda Duska	3
17	Continuous epidural infusion anesthesia and analgesia in gynecologic oncology patients: Less pain, more gain? 2014 ·Gynecologic Oncology ·Madeleine Courtney‐Brooks, (unknown), (unknown), John Nakayama, Linda Duska	10
18	An analysis of vulvar necrotizing fasciitis in the unique and ethnically diverse Hawaiian population. 2010 ·PubMed ·John Nakayama, (unknown)	19
19	High Poly(Adenosine Diphosphate-Ribose) Polymerase Expression and Poor Survival in Advanced-Stage Serous Ovarian Cancer 2009 ·Obstetrics and Gynecology ·Jason C. Barnett, Sarah M. Bean, John Nakayama, Eiji Kondoh, Susan K. Murphy, Andrew Berchuck	15
20	A case report of adult croup: a new old problem. 2005 ·PubMed ·John Nakayama, (unknown)	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact